Status:
COMPLETED
Does Serum Procalcitonin Levels Predict Sepsis in Patients Undergoing Cytoreductive Surgery
Lead Sponsor:
Eastern Regional Medical Center
Conditions:
Cytoreductive Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Serum procalcitonin levels will be considerably higher, for a longer period of time, in patients who develop sepsis compared to patients with SIRS or those who have an uncomplicated post-surgical reco...
Eligibility Criteria
Inclusion
- Female or male person ≥ 18 years of age
- Biopsy proven carcinoma
- Scheduled for cytoreductive surgery, with or without HIPEC
- Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0, 1, or 2
- Able to give informed consent for protocol participation
Exclusion
- Participants are not able to understand or provide written informed consent
- Pre-operative anti-inflammatory medication use within 72 hours of their baseline blood draw
- Pre-operative infection treatment with corticosteroids within 72 hours of their baseline blood draw
- Immunosuppressive illness other than neoplasm
- Pregnant or lactating female
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02189434
Start Date
June 1 2014
End Date
April 1 2016
Last Update
July 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eastern Regional Medical Center
Philadelphia, Pennsylvania, United States, 19124